Junín virus

background-color: rgb(250,250,190)" background-color: rgb(250,250,190)"

colspan=2 style="text-align: center; background-color: rgb(250,250,190)" | Junín virus
Electron micrograph of Junín virus
colspan=2 style="min-width:15em; text-align: center; background-color: rgb(250,250,190)" | Virus classification
Species	Junín mammarenavirus

The Junín virus is a member of the Arenaviridae family, specifically classified under the genus Mammarenavirus. It is the causative agent of Argentine hemorrhagic fever (AHF), a severe and often fatal disease endemic to certain agricultural regions of Argentina. The virus is named after the city of Junín in Argentina, where the disease was first identified.

Virology

The Junín virus is an enveloped virus with a bi-segmented, single-stranded RNA genome. Like other arenaviruses, it has a characteristic sandy appearance under the electron microscope due to the presence of ribosomes within the virion. The genome consists of two segments, designated as L (large) and S (small), which encode for the viral polymerase, nucleoprotein, glycoproteins, and a zinc-binding protein.

Transmission

The primary reservoir of the Junín virus is the Calomys musculinus, a rodent species commonly found in the pampas of Argentina. Human infection occurs through contact with infected rodent excreta, either by inhalation of aerosolized particles or through direct contact with broken skin or mucous membranes.

Clinical Manifestations

Argentine hemorrhagic fever presents with a wide range of symptoms, typically beginning with a prodromal phase characterized by fever, malaise, and myalgia. As the disease progresses, patients may develop hemorrhagic manifestations, neurological symptoms, and shock. The case fatality rate can be as high as 30% without treatment.

Diagnosis

Diagnosis of Junín virus infection is primarily based on clinical suspicion in endemic areas, followed by laboratory confirmation. Serological tests, such as ELISA, can detect specific antibodies, while RT-PCR is used for direct detection of viral RNA in blood samples.

Treatment and Prevention

The antiviral drug Ribavirin has shown efficacy in reducing mortality if administered early in the course of the disease. Supportive care, including fluid management and treatment of secondary infections, is crucial. A live-attenuated vaccine, known as the Candid #1 vaccine, is available and has been effective in reducing the incidence of AHF in endemic regions.

Epidemiology

Junín virus is endemic to the pampas region of Argentina, particularly affecting rural agricultural workers. Outbreaks are often associated with increased rodent populations and human encroachment into rodent habitats.

Research

Ongoing research on Junín virus focuses on understanding its pathogenesis, improving diagnostic methods, and developing more effective treatments and vaccines. Studies on the molecular biology of the virus aim to elucidate mechanisms of virulence and host immune response.

Also see

• Arenavirus
• Argentine hemorrhagic fever
• Ribavirin
• Viral hemorrhagic fever